NHL, NHLPA Aim For Big Money World Cup Roberts Challenges Silver As She Settles In Deadline Looms Over ATP Prize Money Dispute LPGA Finishes Season On High Note Goodell Won't Hear Peterson Appeal Sources: Manfred To Merge MLB's Business League Notes Peterson Opens Up Following NFL Suspension Roberts Says Taylor Suspension Was Excessive Minneapolis Area Official Chooses Side In MLS Bid
SBD/Issue 36/Leagues & Governing Bodies
MLB Teams Have Advanced Warning When Drug Tests Will Occur
Published October 31, 2007
MLB-contracted drug testers "routinely alert team officials a day or more before their arrival at ballparks for what is supposed to be random, unannounced testing of players," a process anti-doping experts claim "undermines the integrity of the testing program," according to a front-page piece by Michael Schmidt of the N.Y. TIMES. Teams are not told what players will be tested, but drug-testing companies call the home team the night before to request stadium and parking passes. Doping expert John Hoberman said, "They're opening a door to serious doubts about the integrity of the program." Officials from three teams "confirmed that their clubs receive advance notice of testing." MLB Exec VP/Labor Relations Rob Manfred, who oversees MLB's drug-testing program, said clubs "are not supposed to tell players that tests will be conducted," and added a person with each team "is responsible for arranging for tester access and for space to be set aside in the locker rooms for tests." Manfred: "We are very confident that no player has ever received advanced notice of a test. Even if a player knew a few hours before, there is precious little that can be done to subvert a test." In May, MLB "quietly adjusted its testing procedure" after a report described how MLB drug testers "relied on team employees to chaperone players who could not immediately provide a urine sample." MLB Senior VP/PR Rich Levin said, "The process continues to evolve, we have an open mind, and if there is a way to make it better we will do it" (N.Y. TIMES, 10/31).